The reiteration of a Buy rating and maintenance of an $81 price target by a reputable analyst like Gil Blum from Needham is likely to instill confidence among investors and could positively influence Immunocore Holdings' stock price in the short term. Analyst ratings, especially with a Buy recommendation, tend to have a positive impact on stock prices as they reflect the analyst's confidence in the company's future performance.